FDA Inspection 1094794 — Wendy C. Daly, M.D.

Wendy C. Daly, M.D. — FEI 3015282688

The FDA completed an inspection of Wendy C. Daly, M.D. on July 1, 2019 in Louisville, KY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 1, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Louisville, KY (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
752021 CFR 312.64(b)Safety reports
753021 CFR 312.62(b)Case history records- inadequate or inadequate